Please wait...
GulfBase Live Support
- TAQA Group reports Q1 revenue of $ 3.87bn, up 3.8%
- Bahrain All Share Index closes higher
- UAE airline Etihad places major aircraft order with Boeing
- UN forecasts global economic growth to drop to 2.4% in 2025
- Dubai gold rate shoots up after Dh10 plus drop - in hours
- Abraj Energy signs deal with BP for drilling rig in Block 61
- Commercial Bank launches new CB Corporate Banking App
- QSE sees 62% of stocks in the red; index loses 19 points
- Financial markets development essential to Qatar's comprehensive financial strategy: QCB Governor
- Emirates NBD pilots new AI compliance tech to reduce risks, improve payment speed
- JAMJOOMPHARMA
- :183.4
- :178.2
- ('000):70,000
- ( '000):12,600,000
- :0
-
102,045 - :0
- :
- 11.07%
- 40.41%
-
1,657 -
():
18,390,797.6 - ():13,266,666
- :1.39
- Performance Comparison
- :Saudi Stock Exchange
- :Pharma, Biotech & Life Science
- :Small Cap
- :Health Care
Company Overview
- :22/09/1994
- :SAR 700,000,000
- :SAR 10
Activities
Jamjoom Pharmaceuticals Factory is a Saudi joint stock company specialized in developing, manufacturing, marketing and selling generic pharmaceutical products, cosmetics, and healthcare products to consumers. Founded in 2000, the company quickly emerged as one of the leading pharmaceutical companies in the Middle East, Africa and CIS regions. Jamjoom Pharma is ranked among the top 5 pharmaceutical companies globally (IMS) and occupies third place in the total pharmaceutical market in Saudi Arabia (IQVIA). The company has received praise from Frost & Sullivan for its dominance in the pharmaceutical market in Saudi Arabia. In addition, Mr. Nour Sherif, Managing Director, was honored with the European Business Association (EBA) Manager of the Year Award for Innovative Business Strategies. Jamjoom Pharma operates modern manufacturing facilities managed by specialized teams. The company exports its products to more than 30 countries. The company is distinguished by the high quality of its products and its wide distribution network, making it one of the leading companies in the region.
-
Chairman:Mahmoud Y. S. Jamjoom
-
Vice-chairman:Ahmed Y. M. Jamjoom
-
CEO:Tarek Y. Hosni
-
General Manager:
-
Managing Director:
-
Board Members:
Ahmed Y. M. Jamjoom
Alaa Y. M. Salah Jamjoom
Faris I. A. Al-Ghannam
Georges P. Schorderet
Michel M. J. Le Bars
Mohammed Y. M. Jamjoom
Noor A. K. Sheriff
Yousuf M. S. Jamjoom
-
Auditors:
KPMG Professional Services
CFO
Global Manufacturing Officer
Head of Legal Department
HR Director
Commercial Director
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 30/04/2025 | 3-Month | 31/03/2025 | 157 | 52.5 |
| 25/02/2025 | 12-Month | 31/12/2024 | 357 | 21.93 |
| 27/10/2024 | 9-Month | 30/09/2024 | 305 | 22.99 |
| 06/08/2024 | 6-Month | 30/06/2024 | 210 | 23 |
| 09/05/2024 | 3-Month | 31/03/2024 | 103 | 22 |
- IR@Jamjoompharma.com
- www.jamjoompharma.com
- P.O. Box 6267 Jeddah 21442
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 25,184.25 | 268 | -0.75 | -2.58 | 42.44 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,196.24 | 2.7 | -0.37 | 0 | 26.81 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,881.26 | 89.8 | -0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 4,219.76 | 122.2 | 0.32 | -15.6 | 19 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 4,136.08 | 76.7 | -1.16 | -28.46 | 23.58 | 2.79 | 0 | 0.81 | 13.85 | 22.49 |
| JAMJOOMPHARMA | 3,357.9 | 180 | 0 | 18.09 | 36.06 | 0 | 0 | 0 | 0 | 0 |
| DALLAHHEALTH | 3,087.39 | 117 | -1.35 | -5.63 | 24.6 | 4.31 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,865.73 | 46.5 | 0.32 | 0 | 39.94 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,141.59 | 115.8 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,941.09 | 166.2 | 2.33 | -16.19 | 26.54 | 7.55 | 0 | 0.85 | -0.59 | -0.89 |
| NABAALSAHA | 1,922.4 | 67.2 | -2.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TIBBIYAH | 1,700.27 | 31.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,569.83 | 63.3 | -1.1 | -28.25 | 27.87 | 3.61 | 0 | 0.79 | 11.92 | 18.76 |
| PROMEDEX | 892.64 | 95.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 863.46 | 26.9 | -0.38 | -2.21 | 80.02 | 1.23 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 784.84 | 32 | 3.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 688.64 | 126.8 | -1.86 | 0 | 32.12 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 621.48 | 116.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 524.21 | 789 | 0 | -4.78 | 14.01 | 1.38 | 0 | 0 | 12.06 | 17.87 |
| QOMEL | 508.35 | 55 | 0.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JULPHAR | 446.52 | 1.38 | -2.82 | 0 | -71.36 | 0.69 | 5.27 | 0.2 | 4.09 | 0 |
| AYYAN | 401.76 | 14.7 | -1.87 | -8.1 | -7.15 | 1.5 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 393.81 | 2.14 | 3.38 | 0 | 0 | 1.1 | 3 | -0.08 | 75.81 | 111.42 |
| ATC.KW | 364.68 | 741 | 0 | 0 | 157.88 | 2.25 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 346.4 | 4.64 | 2.65 | -0.04 | 21.18 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 324.2 | 39.9 | -1.61 | 5.1 | 25.3 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 229.4 | 22 | 2.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 223.75 | 4.21 | 2.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 209.69 | 1.46 | -1.36 | 0 | 1.65 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 143.64 | 6.93 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 113.8 | 18.12 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 50.77 | 3.73 | -2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 43.09 | 1.37 | 0 | 16.69 | -2.31 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 30.65 | 5.72 | -0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 25.65 | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 17.09 | 42.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 14.49 | 16.6 | -1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia